home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

961 rows where filing_year = 2013 and issue_code = "PHA" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, is_termination, received_date (date)

filing_period 4

  • second_quarter 254
  • fourth_quarter 244
  • third_quarter 238
  • first_quarter 225

issue_code 1

  • PHA · 961 ✖

filing_year 1

  • 2013 · 961 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
1368488 AMERICAN COLLEGE OF CLINICAL PHARMACY addacb28-6dbf-4ea2-9af1-1c830fc52cea Q1 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2013 first_quarter PHA Coverage for direct patient care services of qualified pharmacists under Medicare and other public health programs. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   111725 0 0 2013-04-01T11:54:32.130000-04:00
1369234 UNIVERSITY OF IOWA d15d1944-6d6b-4b94-9a3c-4cc502798711 Q1 UNIVERSITY OF IOWA 49191 UNIVERSITY OF IOWA 2013 first_quarter PHA Increased appropriations for systems to shorten the time between development of a drug and its release to the public FDA reform as it relates to drug development and research Collaborative research on drug development Human factors research related to neuropharmaceuticals Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Transportation, Dept of (DOT)   29312 0 0 2013-04-08T11:14:59.307000-04:00
1369386 MR. VINCENT A. PANVINI b000f88c-25cf-4d11-877b-7f516f9d81e7 Q1 MR. VINCENT A. PANVINI 401008845 PHRMA 2013 first_quarter PHA Medicare Part D, Transpacific Partnership (TPP) HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2013-04-08T15:12:22.777000-04:00
1369478 VENABLE LLP 4b750e50-de92-4684-985e-71e51e38952f Q1 VENABLE LLP 39941 ENDO PHARMACEUTICALS INC 2013 first_quarter PHA Issues related to tamper resistant formulation of pharmaceuticals drugs. The Life Sciences Jobs and Investment Act. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2013-04-08T16:34:02.147000-04:00
1369813 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 2fcb48b9-c4bc-4314-a58f-52c766e22719 Q1 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 27478 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 2013 first_quarter PHA HR 8, Fiscal Cliff Bill, Diabetic Testing Supplies Provisions; S.644, The Preventing Abuse of Cough Treatments Act of 2013; HR 1285, Making Hydrocodne Schedule II; S. 621, THe Safe Prescribing Act of 2013; HR 1024, The Medication Therapy Management Empowerment Act of 2013; S. 557, The Medication Therapy Management Empowerment Act of 2013; HR 1188, The Preserving our Hometown Independent Pharmacies Act of 2013 SEE ADDENDUMPharmaceutical Supply Chain Security Drug Shortages legislation; Prescription drug diversion and abuse; TRICARE Pharmacy Benefit/Provisions for inclusion in the National Defense Authorization Act; Deficit Reduction Issues; Pharmacy Preferred Networks issues Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Office of Personnel Management (OPM),SENATE   250000 0 0 2013-04-09T16:31:30.740000-04:00
1369844 MR. VINCENT A. PANVINI 0dcb0dd8-fdc0-4563-a3ba-8050af284c1c 1A MR. VINCENT A. PANVINI 401008845 ELI LILLY AND COMPANY 2013 first_quarter PHA Medicare Part D, Transpacific Partnership HOUSE OF REPRESENTATIVES,SENATE     0 0 2013-04-09T20:52:51.587000-04:00
1370015 VORYS ADVISORS, LLC 659dcbf3-b858-4566-b129-ff0dfbff6dfd Q1 VORYS ADVISORS, LLC 400873558 AMERISOURCEBERGEN CORPORATION 2013 first_quarter PHA Various health care proposals HOUSE OF REPRESENTATIVES     0 0 2013-04-10T11:35:35.093000-04:00
1370051 DUTKO WORLDWIDE, LLC eb2cdc25-d254-4b3a-b873-79caefbf545b Q1 DUTKO WORLDWIDE, LLC 12868 NEWAYS INTERNATIONAL 2013 first_quarter PHA Monitor legislation pertaining to dietary supplements and pharmaceuticals, particularly the Food Safety Modernization Act (PL 111-353) and Patient Protection and Affordable Care Act (PL 111-148). Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2013-04-10T11:59:54.500000-04:00
1370137 THORSEN FRENCH ADVOCACY LLC feade8d9-b3d0-4607-b0b7-5cc3a7bc6967 Q1 THORSEN FRENCH ADVOCACY LLC 400599826 ASTRAZENECA PHARMACEUTICALS LP 2013 first_quarter PHA Issues realted to access to pharmaceuticals. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2013-04-10T12:52:50.307000-04:00
1370241 MCDERMOTT WILL & SCHULTE LLP fe61eff3-bc25-41a3-b7ad-ea69144d354c Q1 MCDERMOTT WILL & SCHULTE LLP 24338 ALLERGAN, INC. 2013 first_quarter PHA Issues related to Section 340B of the Public Health Service Act; FDA issues; health reform implementation Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 100000   0 0 2013-04-10T14:38:08.220000-04:00
1370423 MERCURY PUBLIC AFFAIRS, LLC fcd37c9d-f6a9-4c9f-a007-1677690c09f6 1T MERCURY PUBLIC AFFAIRS, LLC 70175 EXPRESS SCRIPTS INC. 2013 first_quarter PHA Prescription drug monitoring. HOUSE OF REPRESENTATIVES,SENATE 40000   0 1 2013-04-10T16:48:51.917000-04:00
1370474 INJURED WORKERS PHARMACY 893fbb49-c781-4729-bbf8-5116ff96e2dc Q1 INJURED WORKERS PHARMACY 400765309 INJURED WORKERS PHARMACY 2013 first_quarter PHA Transparency of Pharmacy Benefit Managers (bill sponsored by Rep. McMorris-Rodgers and Senator Mark Pryor); Longshoreman and Harbor Workers Amendment Act of 2011 sponsored by Senator Isakson. HOUSE OF REPRESENTATIVES,SENATE     0 0 2013-04-11T09:16:24.133000-04:00
1370742 UPS (UNITED PARCEL SERVICE) 6ee35984-417e-41bc-a8df-567f5172e7b1 Q1 UPS (UNITED PARCEL SERVICE) 39223 UPS (UNITED PARCEL SERVICE) 2013 first_quarter PHA - HR 2405 / S.1855 Healthcare Supply Chain Safety - track and trace in the Prescription Drug Users Fee Act Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Executive Office of the President (EOP),Federal Aviation Administration (FAA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Joint Chiefs of Staff,Labor, Dept of (DOL),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT),Treasury, Dept of,U.S. Trade Representative (USTR),White House Office   1427716 0 0 2013-04-11T14:05:35.967000-04:00
1371271 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 3b302417-cd62-4531-a699-0e92a20fc1d7 Q1 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 29403 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 2013 first_quarter PHA Over-the-counter (OTC) medicines; Manufacturing and importation of OTC drugs; mandatory recall authority of the FDA; Rx-to-OTC SwitchSupporting a process within FDA that ensures clarity and timely outcomes for the FDA, applicants and stakeholders, as well as utilizing existing technologies to further streamline the prescription-to-nonprescription switch application process without changing the existing clear distinction between prescription and nonprescription medicines. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE   260000 0 0 2013-04-12T16:32:45.613000-04:00
1371503 HEARTLAND SOLUTIONS GROUP, INC. 466679d2-c639-4cd8-a44a-2fef9f34b481 Q1 HEARTLAND SOLUTIONS GROUP, INC. 312133 ZEBRA TECHNOLOGIES CORPORATION 2013 first_quarter PHA Any and all issues related to barcode, secure identification and real-time location systems. HOUSE OF REPRESENTATIVES,SENATE 48000   0 0 2013-04-14T18:36:38.783000-04:00
1371733 OMNICARE, INC. 3ccbbed5-1798-4cad-b9a8-286dd62b918e Q1 OMNICARE, INC. 321112 OMNICARE INC 2013 first_quarter PHA Drug Enforcement Administration proposed rule on disposal of controlled substances in long term care facilities. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE   100000 0 0 2013-04-15T11:07:47.140000-04:00
1371975 ANIMAL HEALTH INSTITUTE f1189876-16e6-4dde-b8dc-709c20dc7a5c Q1 ANIMAL HEALTH INSTITUTE 4037 ANIMAL HEALTH INSTITUTE 2013 first_quarter PHA Issues related to pharmacy compounding; veterinary Drug Enforcement Administration issues - Veterinary Medicine Mobility Act of 2013. HOUSE OF REPRESENTATIVES,SENATE,White House Office   55000 0 0 2013-04-15T12:52:25.743000-04:00
1372281 NAHIGIAN STRATEGIES, LLC a1f3a54d-79e0-4b72-98c1-bb04954e7577 Q1 NAHIGIAN STRATEGIES, LLC 322897 TEVA PHARMACEUTICALS USA INC 2013 first_quarter PHA Generic pharmaceutical issues, including patent settlements, and regulatory. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2013-04-15T14:33:08.317000-04:00
1372383 PARRY, ROMANI, DECONCINI & SYMMS acfe7cf1-d80e-4d50-a5d1-54cfd3c1e769 Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 POZEN, INC. 2013 first_quarter PHA To provide incentives for new drug development. No specific bills pending. HOUSE OF REPRESENTATIVES,SENATE 36000   0 0 2013-04-15T15:03:20.263000-04:00
1372463 SHELTER ROCK STRATEGIES, LLC 196238f4-99e8-4c55-9ef4-85675abc3fe8 Q1 SHELTER ROCK STRATEGIES, LLC 400772326 NEW YORK MEDICAL COLLEGE 2013 first_quarter PHA BARDA Solicitation HHS 11-100SOL-00011, Centers for Innovation in Advanced Development and Manufacturing, Assess the likelihood this solicitation will get funded, assess competition, assist in writing and getting signed memoranda of support from the New York Congressional Delegation, and assist in obtaining support from New York State to aide the client's proposal. SENATE     0 0 2013-04-15T15:40:56.047000-04:00
1373390 NOVO NORDISK INC. 191f222c-deda-42e8-9651-4011daf45bf2 Q1 NOVO NORDISK INC. 284790 NOVO NORDISK INC. 2013 first_quarter PHA Issues regarding Pharmaceutical Traceability Enhancement Code (Rx TEC) Act and discussion draft on serialization (track and trace); S.622 -- Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013 for amendments that would impact human drug user fees; issues regarding biosimilars; 340B Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE   600000 0 0 2013-04-16T14:29:05.360000-04:00
1373440 PARRY, ROMANI, DECONCINI & SYMMS c13d871a-7f47-42a2-8dff-2ab9a99c2203 Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 BRAIDWOOD MANAGEMENT, INC. 2013 first_quarter PHA Issues related to the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2013-04-16T14:47:26.453000-04:00
1373461 PARRY, ROMANI, DECONCINI & SYMMS f23dcbd8-9a87-49c9-b23f-fba879446b4f Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 DIAMONDBACK DRUGS 2013 first_quarter PHA Issues related to the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. HOUSE OF REPRESENTATIVES,SENATE 6000   0 0 2013-04-16T14:53:33.417000-04:00
1373476 PARRY, ROMANI, DECONCINI & SYMMS 5b3485a2-bc54-48cf-9cc9-2966d22c8d60 Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 VETERINARY PHARMACIES OF AMERICA, INC. 2013 first_quarter PHA Issues related to the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2013-04-16T15:00:39.710000-04:00
1373499 PARRY, ROMANI, DECONCINI & SYMMS 7bac7818-33e5-48ed-9aee-974b1255923c Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 WEDGEWOOD VILLAGE PHARMACY, INC. 2013 first_quarter PHA Issues related to the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2013-04-16T15:07:50.657000-04:00
1373530 PARRY, ROMANI, DECONCINI & SYMMS 6c4143a5-3893-4102-b38c-3f527702f812 Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 WOMEN'S INTERNATIONAL PHARMACY, INC. 2013 first_quarter PHA Issues related to the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2013-04-16T15:12:59.027000-04:00
1373618 RED+BLUE STRATEGIES 4b52c97c-df0b-4719-aee2-4a278ee35e1d Q1 RED+BLUE STRATEGIES 400693064 EXPRESS SCRIPTS INC. 2013 first_quarter PHA H.R. 1367 - FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act - focused on policies that would negatively impact access to mail order pharmacy Rules, regulations and guidance specific to prescription drug pricing, generic utilization and specialty pharmacy.Issues impacting PBMs in up coming health related legislation. Policies related to stopping the diversion of prescription medications in the nation's drug supply chain. Changes in International Naming policies for generic medications. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2013-04-16T15:44:37.750000-04:00
1373661 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 1d7c3629-aba5-40d8-b420-cf093f0ff80b Q1 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 28776 HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA) 2013 first_quarter PHA Rx Pedigree; Prescription Drug Monitoring Programs; Drug Abuse (S. 348), Hydrocodone Rescheduling (H.R. 1285, S. 621); Dextromethorphan (S. 644); Drug Shortages; Counterfeit Drugs; Importation of Prescription Drugs Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   286000 0 0 2013-04-16T16:02:50.927000-04:00
1373708 AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP) 6953e519-86f6-4216-a34c-9748518a2577 Q1 AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP) 1581 AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) 2013 first_quarter PHA H.R. 1367, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act16. Specific Lobbying Issues (continued): (Lynch) FEHBP prescription drugs S. 214, Preserve Access to Affordable Generics Act (Klobuchar) access to generic drugs Regulatory Issues: Issues relating to long term safety and effectiveness of medical devices and drugs, including registries; issues relating to post-market surveillance of drugs and medical devices; issues relating to access for investigational drugs; and other issues relating to health care reform implementation. Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Federal Bureau of Investigation (FBI),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Justice, Dept of (DOJ),Labor, Dept of (DOL),Medicare Payment Advisory Commission (MedPAC),Office of Management & Budget (OMB),Office of Personnel Management (OPM),Pension & Welfare Benefits Administration,SENATE,Treasury, Dept of,White House Office   2490000 0 0 2013-04-16T16:32:19.323000-04:00
1373716 INDEPENDENT PHARMACY COOPERATIVE 6f53ad81-089a-437b-b038-59fb1a6fcb61 Q1 INDEPENDENT PHARMACY COOPERATIVE 313098 INDEPENDENT PHARMACY COOPERATIVE 2013 first_quarter PHA Tax Payer Relief Act 2013 Implementation of Diabetic Supply Reimbursement Changes Centers For Medicare and Medicaid Services (CMS)     0 0 2013-04-16T16:35:25.167000-04:00
1373850 CAPITOL HILL CONSULTING GROUP 31728ec1-8c70-4bdd-a4cf-1cdc5b3eea31 Q1 CAPITOL HILL CONSULTING GROUP 72053 PROFESSIONAL COMPOUNDING CENTERS OF AMERICA 2013 first_quarter PHA Compounding pharmacy and FDA issues HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2013-04-16T17:28:16.090000-04:00
1373974 THE INGRAM GROUP LLC d8b45cf6-d5e5-4771-95d8-8f06b48be2f7 Q1 THE INGRAM GROUP LLC 400577737 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) 2013 first_quarter PHA Issues related to pharmaceutical importation, issues related to generic drugs, and S.CON.RES.8, An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2014, revising the appropriate budgetary levels for fiscal year 2013, and setting forth the appropriate budgetary levels for fiscal years 2015 through 2023. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2013-04-16T22:37:03.437000-04:00
1374059 MEHLMAN CONSULTING, INC. 8215a15a-b6fe-4d37-8ebb-9a0288ac76dd Q1 MEHLMAN CONSULTING, INC. 284950 PROCTER & GAMBLE 2013 first_quarter PHA Preventing Abuse of Cough Treatments Act of 2013 (S. 644) Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2013-04-17T09:33:34.577000-04:00
1374470 COVIDIEN LP 4acb5b81-b484-4afb-96e3-cd785ee576f0 Q1 COVIDIEN LP 319778 COVIDIEN LP 2013 first_quarter PHA Issues involving controlled substances and pain and addiction drugs generally. Energy, Dept of,Executive Office of the President (EOP),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE,State, Dept of (DOS)   720000 0 0 2013-04-17T11:43:57.443000-04:00
1374555 ACG ADVOCACY ef9208bf-c470-4a5f-b036-deb82045a15e Q1 ACG ADVOCACY 2057 GENENTECH INC 2013 first_quarter PHA Tamiflu. HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR) 40000   0 0 2013-04-17T12:00:34.867000-04:00
1374703 CAPITOL HILL CONSULTING GROUP 831d177d-15d3-45d6-8dfb-b71e3e1e8dc0 Q1 CAPITOL HILL CONSULTING GROUP 72053 PURDUE PHARMA LLP 2013 first_quarter PHA Controlled Drug Substances Act (21 USC 13) Stop Oxy Abuse Act Stop Tampering of Prescription Pills Act of 2013 (H.R. 486) HOUSE OF REPRESENTATIVES,SENATE 47000   0 0 2013-04-17T12:34:47.713000-04:00
1374767 CYBER SECURITY RESEARCH CONSULTANTS, LLC 680308e7-cbb8-4c34-afe0-115e98048057 Q1 CYBER SECURITY RESEARCH CONSULTANTS, LLC 91694 PDFRAZER CONSULTING INC CANADIAN INTERNATIONAL PHARMACY ASSOCIATION 2013 first_quarter PHA Monitoring drug importation legislation SENATE 21000   0 0 2013-04-17T12:50:23.843000-04:00
1375233 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 9be52443-0233-464e-9cc1-65c5947a682c Q1 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 3457 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 2013 first_quarter PHA Contact concerning Food and Drug Administration (FDA) authority to manage drug shortages. Communication to FDA on Drug Shortages Task Force. Communication with Drug Enforcement Administration (DEA) on Central Fill of Controlled Substances. Communication with FDA and Center for Disease Control and Prevention on compounding. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   250000 0 0 2013-04-17T14:54:24.027000-04:00
1375436 HAAKE & ASSOCIATES c1bf12a6-c427-454e-970a-e57680c154ce Q1 HAAKE & ASSOCIATES 17226 JOHNSON & JOHNSON SERVICES INC. 2013 first_quarter PHA Policy and procurement matters related to vaccines Air Force, Dept of,Army, Dept of (Other),Defense, Dept of (DOD),Defense Logistics Agency,Navy, Dept of,U.S. Marines 20000   0 0 2013-04-17T15:33:54.123000-04:00
1375589 THE OB-C GROUP, LLC 966d9413-5a33-4057-9011-f9c2138f12b7 Q1 THE OB-C GROUP, LLC 29802 ELI LILLY 2013 first_quarter PHA No specific bill number: matters relating to pharmaceutical manufacturers and Medicare Part D. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2013-04-17T16:05:51.720000-04:00
1375611 NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC affca1e2-338d-4145-b3ac-128ae2fe7a7d Q1 NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC 400689052 WOCKHARDT USA LLC 2013 first_quarter PHA Issues affecting settlement of litigation between NDA and ANDA holders HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2013-04-17T16:15:00.197000-04:00
1375912 C2 GROUP, LLC 1542b2f9-ed13-44f0-93c1-874a3f9e2349 1T C2 GROUP, LLC 66693 AMERICAS HEALTH INSURANCE PLANS (AHIP) 2013 first_quarter PHA H.R. 1367, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act (Lynch) - FEHBP prescription drugs. S. 214, Preserve Access to Affordable Generics Act (Klobuchar) - access to generic drugs. HOUSE OF REPRESENTATIVES,SENATE 50000   0 1 2013-04-17T19:22:13.410000-04:00
1375995 THORN RUN PARTNERS f4a53cfa-cda2-4bf6-b976-0e9964bd89a5 Q1 THORN RUN PARTNERS 400534596 LONG TERM CARE PHARMACY ALLIANCE 2013 first_quarter PHA Issues related to short-cycle dispensing. Issues related to PBM audit legislation. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2013-04-17T22:20:20.713000-04:00
1376028 C2 GROUP, LLC f4375d11-a70c-42a5-bee2-0d1629b3a0fb 1T C2 GROUP, LLC 66693 PERRIGO INC 2013 first_quarter PHA OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. GDUFA H.R.5651, S.3187. Fairness to Pet Owners Act. HOUSE OF REPRESENTATIVES,SENATE 50000   0 1 2013-04-17T22:54:33.513000-04:00
1376173 PD FRAZER CONSULTING, INC. a619ba6f-dd65-4403-b469-e7dfaad75687 Q1 PD FRAZER CONSULTING, INC. 65998 CANADA INTERNATIONAL PHARMACY ASSOCIATION 2013 first_quarter PHA Monitor the development of proposed bills about the importation of prescription drugs. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2013-04-18T08:48:42.397000-04:00
1376175 WEXFORD STRATEGIC ADVISORS, INC. a941e1d2-d0a5-4678-b894-02161657b9d0 Q1 WEXFORD STRATEGIC ADVISORS, INC. 401047947 P.D. FRAZER CONSULTING, INC., CANADIAN INTERNATIONAL PHARMACY ASSOCIATION 2013 first_quarter PHA Monitor the development of proposed bills about the importation of prescription drugs. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2013-04-18T08:52:43.657000-04:00
1376395 ATRIUM HEALTH-FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM 0d6d6a0f-0a8d-441f-8619-0c42dddabbae Q1 ATRIUM HEALTH-FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM 58534 ATRIUM HEALTH - FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM 2013 first_quarter PHA Any legislation related to the 340B Drug Discount Program or changes contemplated by members of Congress. HOUSE OF REPRESENTATIVES,SENATE   58855 0 0 2013-04-18T10:36:21.467000-04:00
1376700 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 98d71c84-d06d-4740-84f9-cb2fdf3dc7fd Q1 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 26672 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 2013 first_quarter PHA S.644, Preventing Abuse of Cough Treatments Act of 2013 S. 621, Safe Prescribing Act of 2013 H.R. 1285, Safe Prescribing Act of 2013 Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   660000 0 0 2013-04-18T11:28:09.707000-04:00
1376808 RED+BLUE STRATEGIES 52119da8-98f1-48b9-8831-f8b16482d970 Q1 RED+BLUE STRATEGIES 400693064 PEW CHARITABLE TRUSTS 2013 first_quarter PHA Issues related to continuing to increase the supply of new and innovative antibiotics that will help to treat the myriad antibiotic resistant strains of bugs like MRSA.H.R. 933 - Consolidation and Further Continuing Appropriations Act of 2013 - Focused on funding for the FDA, CDC and other public health related industries. H.R. 307 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 - Focus on the potential for language that would allow for greater focus on the need for new antibiotics to enter into the pipeline. Continued work on issues related to downstream supply chain safety of prescription medications Issues related to safety in compounding of certain medications Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2013-04-18T11:57:52.613000-04:00
1376827 GREATER NEW YORK HOSPITAL ASSOCIATION cdc48891-dbb4-452f-893e-467a014875a7 Q1 GREATER NEW YORK HOSPITAL ASSOCIATION 16830 GREATER NEW YORK HOSPITAL ASSOCIATION 2013 first_quarter PHA Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers, including drug shortage legislation, implementation of P.L. 112-144, medical device pricing and tax issues (including gag clauses), and preserving access to group purchasing organizations (GPOs); issues related to drug compounding oversight by Congress; 340b HRSA guidance on the GPO exclusion (HRSA Release 2013-1); FDA mobile health guidance (FDA-2011-D-0530). Centers For Medicare and Medicaid Services (CMS),Federal Emergency Management Agency (FEMA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),SENATE,White House Office   260000 0 0 2013-04-18T12:06:03.280000-04:00
1376883 ELI LILLY AND COMPANY 5b35c265-043f-4d32-bd1b-70c682951925 Q1 ELI LILLY AND COMPANY 13392 ELI LILLY AND COMPANY 2013 first_quarter PHA Hospital discounts (HR 3590) Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Food & Drug Administration (FDA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),U.S. Trade Representative (USTR)   2610000 0 0 2013-04-18T12:17:27.833000-04:00
1376959 NAVIGATORS GLOBAL LLC (FORMERLY DC NAVIGATORS, LLC) 61589511-53c5-4543-a6b7-e3bc58fc99e1 Q1 NAVIGATORS GLOBAL LLC (FORMERLY DC NAVIGATORS, LLC) 85071 UNITED PARCEL SERVICE 2013 first_quarter PHA Issues related to the security and integrity of the domestic pharmaceutical distribution system. HR 2405 and S.1855 - Healthcare Supply Chain Safety - track and trace in the Prescription Drug Users Fee Act HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2013-04-18T12:28:59.743000-04:00
1376974 EXPRESS SCRIPTS, INC. 5ff451e6-f326-49a0-9b5f-8ca21a8a6903 Q1 EXPRESS SCRIPTS, INC. 294416 EXPRESS SCRIPTS, INC. 2013 first_quarter PHA Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit designissues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse. General issues dealing with pharmacy drug compounding. Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Executive Office of the President (EOP),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Labor, Dept of (DOL),SENATE,White House Office   445817 0 0 2013-04-18T12:32:05.383000-04:00
1377223 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) dd1d63eb-c05d-4861-8e14-346cb21f8927 1A HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 28776 HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA) 2013 first_quarter PHA Rx Pedigree; Prescription Drug Monitoring Programs; Drug Abuse (S. 348), Hydrocodone Rescheduling (H.R. 1285, S. 621); Dextromethorphan (S. 644); Drug Shortages; Counterfeit Drugs; Importation of Prescription Drugs Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   286000 0 0 2013-04-18T13:32:34.460000-04:00
1377245 BROWN RUDNICK LLP 5ea54ade-f394-420f-bd47-65556ae02a08 Q1 BROWN RUDNICK LLP 287895 HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC 2013 first_quarter PHA issues relating to pharmaceutical pedigree. S. 621 & H.R. 1285 - Safe Prescribing Act HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2013-04-18T13:35:41.523000-04:00
1377749 AMERICAN SOCIETY OF CONSULTANT PHARMACISTS 61b7ecc4-4f8e-40de-8213-63b8d20ba1c4 Q1 AMERICAN SOCIETY OF CONSULTANT PHARMACISTS 3446 AMERICAN SOCIETY OF CONSULTANT PHARMACISTS 2013 first_quarter PHA S. 1560 (the Nursing Home Resident Pain Relief Act of 2011), implementation of electronic health records and health information technology HOUSE OF REPRESENTATIVES,SENATE     0 0 2013-04-18T14:46:12.823000-04:00
1378152 KATE MOSS a1eb6896-66ac-4046-bc01-63bc8546d213 Q1 KATE MOSS 25988 CVS HEALTH 2013 first_quarter PHA Issues related to prescription drug abuse and drug supply chain safety. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2013-04-18T15:23:39.090000-04:00
1378176 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. a89bad4b-3233-47a9-9adc-f398bd19b1e1 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 AMERICAN SOCIETY OF HEMATOLOGY 2013 first_quarter PHA Issues related to drug shortages. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2013-04-18T15:27:51.757000-04:00
1378198 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 844375e8-2c4d-4828-8ad9-fab052a17775 1A CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 AMERICAN SOCIETY OF HEMATOLOGY 2013 first_quarter PHA Issues related to drug shortages. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2013-04-18T15:31:00.130000-04:00
1378263 PHILIP W. JOHNSTON ASSOCIATES a8a14566-3e86-4c39-82f4-fcc85aace882 Q1 PHILIP W. JOHNSTON ASSOCIATES 400278335 LUMARA HEALTH (FKA KV PHARMACEUTICAL COMPANY) 2013 first_quarter PHA Legislation regulationg compounding pharmacies to improve patient safety. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2013-04-18T15:36:19.487000-04:00
1378278 WHITMER & WORRALL, LLC b810955c-1412-4900-87ae-83bc9133611a Q1 WHITMER & WORRALL, LLC 292892 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) 2013 first_quarter PHA Issues related to monitoring healthcare reform. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2013-04-18T15:38:25.967000-04:00
1378304 FAEGRE BAKER DANIELS CONSULTING 6b1b406c-d5c0-48c6-9484-b9ff3b372b1f Q1 FAEGRE BAKER DANIELS CONSULTING 34158 ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP) 2013 first_quarter PHA Online pharmacies - S. 2002 and HR 4095 Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE     0 0 2013-04-18T15:43:40.357000-04:00
1378384 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 9ce3b964-3ef0-4152-892f-f2b9c186a93a Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL ASSOCIATION OF EPILEPSY CENTERS 2013 first_quarter PHA Issues related to anti-epileptic drugs. Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 10000   0 0 2013-04-18T15:53:17.193000-04:00
1378447 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. da12160a-3ea3-4c4b-9026-3fec48d51afd Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL HEMOPHILIA FOUNDATION 2013 first_quarter PHA Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program. HR 460 - Patients Access to Treatment Act Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 50000   0 0 2013-04-18T15:58:41.140000-04:00
1378463 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 2956a738-497c-48b6-9114-6ebc90ff58ff Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 THE HEMOPHILIA ALLIANCE 2013 first_quarter PHA Issues realted to the 340B drug discount program. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2013-04-18T15:59:50.640000-04:00
1378983 NOSSAMAN LLP 1295f9fe-05e5-4f04-82ac-4b90ef454df5 Q1 NOSSAMAN LLP 29846 AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") 2013 first_quarter PHA (H.R.800) legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Pharmaceutical pedigree anti-counterfeiting legislation. Legislation pertaining to drug manufacturing shortages. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2013-04-18T16:48:27.007000-04:00
1379326 KAISER FOUNDATION HEALTH PLAN INC. 5844f3fa-3dd0-48fc-a8fe-688313708990 Q1 KAISER FOUNDATION HEALTH PLAN INC. 21027 KAISER FOUNDATION HEALTH PLAN INC 2013 first_quarter PHA S 2002 - Online Pharmacy Safety Act: To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of Internet pharmacies. Sponsor: Feinstein (CA) Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   260000 0 0 2013-04-18T18:33:14.157000-04:00
1379588 BLUESTONE STRATEGIES, LLC 2e76666b-3130-49e6-9e24-c84c9c818e56 Q1 BLUESTONE STRATEGIES, LLC 400658980 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) 2013 first_quarter PHA Pharmacy Act, Genergic Brand Settlement; Generic Dispensing; Generic Biologics; and Specialty Drug Issues. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2013-04-18T22:51:25.957000-04:00
1379872 WINSTON & STRAWN LLP 19767c1a-9e74-43bb-98a8-e0f99a287165 Q1 WINSTON & STRAWN LLP 41682 FRESENIUS KABI USA (FORMERLY KNOWN AS APP PHARMACEUTICALS INC ) 2013 first_quarter PHA Represent the client on issues related to assuring a safe, reliable supply of heparin and also on patent matters, including settlements and extensions. HOUSE OF REPRESENTATIVES,SENATE     0 0 2013-04-19T09:50:18.763000-04:00
1380350 AMERICAN VETERINARY MEDICAL ASSOCIATION fa369b8b-fd48-490d-9204-a6aacfab02e9 Q1 AMERICAN VETERINARY MEDICAL ASSOCIATION 3630 AMERICAN VETERINARY MEDICAL ASSOCIATION 2013 first_quarter PHA S. 622/H.R. 1407 Animal Drug User Fee Amendments of 2013; H.R. 820 Delivering Antimicrobial Transparency in Animals Act of 2013; Inquiries to and discussions with Federal Trade Commission on veterinary pet prescriptions. Agriculture, Dept of (USDA),Drug Enforcement Administration (DEA),Executive Office of the President (EOP),Federal Trade Commission (FTC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   120000 0 0 2013-04-19T10:51:21.577000-04:00
1380480 THE DUBERSTEIN GROUP INC. 738a86b7-7118-4317-9ddc-d36c27873b3b Q1 THE DUBERSTEIN GROUP INC. 12675 PHRMA INC. 2013 first_quarter PHA Patent settlement between brand and generic drugs - S.Con.Res. 8, An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2014, revising the appropriate budgetary levels for fiscal year 2013, and setting forth the appropriate budgetary levels for fiscal years 2015 through 2023 (Vitter amendment). HOUSE OF REPRESENTATIVES,SENATE 100000   0 0 2013-04-19T11:07:20.903000-04:00
1380644 MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) 3ae9bf8f-7511-4e25-bcff-e9e6ebda18ad Q1 MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) 24486 ALLIED MEDICAL SUPPLY, INC. 2013 first_quarter PHA Issues affecting resellers of pharmaceutical products HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2013-04-19T11:22:25.033000-04:00
1380812 RUBICON ADVISORS, LLC 2a5b208a-5bab-4fd5-9614-f482d1aaf900 Q1 RUBICON ADVISORS, LLC 315091 BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2013 first_quarter PHA Physician Payment Sunshine Act S 2029 Patent Settlements H.R. 14328 .316 Affordable Healthcare Choices Act HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2013-04-19T11:35:34.177000-04:00
1380830 THE DUBERSTEIN GROUP INC. bdf5b631-2c6b-41c2-bd7c-d1295c626132 Q1 THE DUBERSTEIN GROUP INC. 12675 PFIZER INC. 2013 first_quarter PHA Pharmaceutical issues, including track and trace, and drug reimportation. Tampering with prescription pills - HR 486, Stop Tampering of Prescription Pills Act of 2013. Detromethorphan abuse - S 644, PACT Act. HOUSE OF REPRESENTATIVES,SENATE 100000   0 0 2013-04-19T11:36:40.630000-04:00
1380860 RUBICON ADVISORS, LLC 682de13f-ecb7-4243-80d8-3327ffd63aa4 Q1 RUBICON ADVISORS, LLC 315091 TEVA PHARMACEUTICALS USA 2013 first_quarter PHA Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act HOUSE OF REPRESENTATIVES,SENATE 105000   0 0 2013-04-19T11:40:54.097000-04:00
1380870 RUBICON ADVISORS, LLC 1449365e-5ac8-4051-9bce-dc119380ba7d Q1 RUBICON ADVISORS, LLC 315091 WATSON PHARMACEUTICALS INC 2013 first_quarter PHA Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029 HOUSE OF REPRESENTATIVES,SENATE 98000   0 0 2013-04-19T11:42:57.250000-04:00
1381031 AMERICAN ASSOCIATION OF NURSE PRACTITIONERS 8bf56eba-0b68-48ef-a5c8-56ad3163cf8b Q1 AMERICAN ASSOCIATION OF NURSE PRACTITIONERS 401040928 AMERICAN ASSOCIATION OF NURSE PRACTITIONERS 2013 first_quarter PHA Legislation and policies relating to: FDA Drug Safety and Risk Management Advisory Committee January 25 recommendation to reschedule hydrocodone as a Schedule II controlled substanceH.R. 1285 To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug S. 621 - Safe Prescribing Act Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Office of Management & Budget (OMB),SENATE,White House Office   43392 0 0 2013-04-19T12:10:55.853000-04:00
1381074 RUBICON ADVISORS, LLC f654aba0-abfe-4d76-aa7f-9458d262193a Q1 RUBICON ADVISORS, LLC 315091 STATE MUTUAL INSURANCE COMPANY 2013 first_quarter PHA Pharmacy - Compounding HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2013-04-19T12:16:11.367000-04:00
1381154 340B HEALTH 19719f3d-4c76-4895-a601-1f87523356f8 Q1 340B HEALTH 316434 340B HEALTH 2013 first_quarter PHA Discussing the importance of the 340B drug discount program and improving program oversight. Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   187253 0 0 2013-04-19T12:25:38.953000-04:00
1381283 ARNOLD & PORTER KAYE SCHOLER LLP 873fb633-a7b0-43bb-ad32-59656212ca6c Q1 ARNOLD & PORTER KAYE SCHOLER LLP 4301 INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS 2013 first_quarter PHA Issues related to the regulation of the practice of pharmacy compounding. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2013-04-19T12:43:26.280000-04:00
1381681 NATIONAL PATIENT ADVOCATE FOUNDATION 6557139e-d285-4dfd-a35f-683dc1a442d6 Q1 NATIONAL PATIENT ADVOCATE FOUNDATION 28311 NATIONAL PATIENT ADVOCATE FOUNDATION 2013 first_quarter PHA Specialty Tiers, Biosimilars Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   38073 0 0 2013-04-19T13:35:58.567000-04:00
1381846 GOLDEN HORIZONS 8de5379e-d56f-4d03-8cc3-bbd48cae9536 Q1 GOLDEN HORIZONS 44275 GOLDEN HORIZONS 2013 first_quarter PHA Monitor and advocate regarding pharmacy issues impacting Long Term Care and Post Acute Care providers and patients. H.R. 1285/S. 621 - To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug; H.R. 1366 - Stop Oxy Abuse Act of 2013 Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Labor, Dept of (DOL),Medicare Payment Advisory Commission (MedPAC),Natl Labor Relations Board (NLRB),Office of Management & Budget (OMB),SENATE,Veterans Affairs, Dept of (VA),White House Office   94997 0 0 2013-04-19T13:49:57.053000-04:00
1381848 BLANK ROME GOVERNMENT RELATIONS 8917cb74-b1fe-44a6-91c1-bf56d0d1d422 Q1 BLANK ROME GOVERNMENT RELATIONS 6325 WALGREEN CO 2013 first_quarter PHA Issues relating to requiring Pharmacy Benefit Managers annual reporting to Part D plan sponsors of number and total cost of prescriptions under a contract, payments to pharmacies, payments from pharmaceuticals manufacturers and generic and brand name drugs dispensed. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2013-04-19T13:49:58.537000-04:00
1381946 CAPITOLOGIC LLC a51c31b2-6e45-4dc8-b1df-f33aba22a15b Q1 CAPITOLOGIC LLC 400426045 BULALAW, LLC 2013 first_quarter PHA Federal funding of illegal prescription drug market interventions Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institute of Justice,Office of Justice Program,SENATE     0 0 2013-04-19T13:55:32.347000-04:00
1382387 FTI GOVERNMENT AFFAIRS 6bc67b16-871c-4cc1-a402-1ea5513660dc Q1 FTI GOVERNMENT AFFAIRS 401054971 AMERICAS HEALTH INSURANCE PLANS (AHIP) 2013 first_quarter PHA H.R. 1367, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act (Lynch) - FEHBP prescription drugs. S. 214, Preserve Access to Affordable Generics Act (Klobuchar) - access to generic drugs. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2013-04-19T14:30:33.460000-04:00
1382872 TARPLIN, DOWNS & YOUNG, LLC 9ddb652a-3f12-49db-a286-bd9084df865d Q1 TARPLIN, DOWNS & YOUNG, LLC 304736 HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) 2013 first_quarter PHA **see addendum pageImportation of prescription drugs Drug Abuse (S. 348), Hydrocodone Rescheduling (H.R. 1285, S. 621), Dextromethorphan (S. 644) Drug Shortages Rx Pedigree Prescription Drug Monitoring Program Counterfeit Drugs ***, no specific bills, supply chain integrity, prescription drug abuse Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 70000   0 0 2013-04-19T15:00:39.807000-04:00
1382982 FIERCE, ISAKOWITZ & BLALOCK fe421406-5eef-464d-ac20-0a21542fa5cd Q1 FIERCE, ISAKOWITZ & BLALOCK 44812 RICHIE'S SPECIALTY PHARMACY 2013 first_quarter PHA Pharmacy Compounding HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2013-04-19T15:07:16.717000-04:00
1383018 FIERCE, ISAKOWITZ & BLALOCK 64157c7f-f13b-4427-9721-2b637377f740 1T FIERCE, ISAKOWITZ & BLALOCK 44812 SUCAMPO PHARMACEUTICALS, INC. 2013 first_quarter PHA General FDA Issues HOUSE OF REPRESENTATIVES,SENATE 50000   0 1 2013-04-19T15:09:21.827000-04:00
1383076 RASKY PARTNERS, INC. e6f2ebf5-256d-48bf-bbb8-dcd79fe5e97a Q1 RASKY PARTNERS, INC. 297410 ELI LILLY AND CO 2013 first_quarter PHA Monitor biologics related issues, Medicare Part D HOUSE OF REPRESENTATIVES,SENATE 22500   0 0 2013-04-19T15:12:51.997000-04:00
1383181 BOCKORNY GROUP, INC. cf2e49bf-176d-490d-a788-9bd61e1ac087 Q1 BOCKORNY GROUP, INC. 289773 CVS HEALTH INC 2013 first_quarter PHA Issues related to prescription drug abuse and drug supply chain safety. H.R. 1188, Preserving Our Hometown Independent Pharmacies Act of 2013 HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2013-04-19T15:21:38.617000-04:00
1383344 UNIVERSITY OF CONNECTICUT b7989007-c168-4551-9025-51759dc8085b Q1 UNIVERSITY OF CONNECTICUT 39382 UNIVERSITY OF CONNECTICUT 2013 first_quarter PHA Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2014, Monitor FDA salaries and expense issues; and extramural research. Education, Dept of,HOUSE OF REPRESENTATIVES,SENATE   62000 0 0 2013-04-19T15:29:37.737000-04:00
1383421 BRAVO GROUP c548a12a-0b7f-4971-8c21-d1a87899322f Q1 BRAVO GROUP 296293 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA 2013 first_quarter PHA Biopharmaceutical issues including: social and economic value of the biopharmaceutical sector, patient access and safety issues, life science innovation and job impact. HOUSE OF REPRESENTATIVES,SENATE 90000   0 0 2013-04-19T15:34:07.573000-04:00
1383557 BLUECROSS BLUESHIELD OF TENNESSEE 1e211df7-17b7-464f-af19-8f73d5795c30 Q1 BLUECROSS BLUESHIELD OF TENNESSEE 6440 BLUECROSS BLUESHIELD OF TENNESSEE 2013 first_quarter PHA General Pharmacy Issues HOUSE OF REPRESENTATIVES,SENATE   40000 0 0 2013-04-19T15:40:56.133000-04:00
1383594 LNE GROUP ba8574dc-c2fb-42fb-812f-ece2e84cac09 Q1 LNE GROUP 308811 OHIOGUIDESTONE (FORMALLY KNOWN AS GUIDESTONE) 2013 first_quarter PHA Lobbied on pharmacy issues HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2013-04-19T15:42:10.380000-04:00
1383760 MCDERMOTT WILL & SCHULTE LLP af04f41e-668c-4364-b983-99692cd15781 Q1 MCDERMOTT WILL & SCHULTE LLP 24338 ISIS PHARMACEUTICALS 2013 first_quarter PHA Health care and patent legislation to ensure the protection of life-saving medical research and development. HOUSE OF REPRESENTATIVES,SENATE     0 0 2013-04-19T15:51:10.453000-04:00
1383779 LNE GROUP a07aee24-dac4-4b18-8c8b-67deedf9277f Q1 LNE GROUP 308811 INTRINSIQ MATERIALS 2013 first_quarter PHA Lobbied on pharmacy issues HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2013-04-19T15:52:16.547000-04:00
1383796 AMERICAN ACADEMY OF FAMILY PHYSICIANS 982f7d75-4c5f-4044-b37d-70f8da8a2f68 Q1 AMERICAN ACADEMY OF FAMILY PHYSICIANS 1342 AMERICAN ACADEMY OF FAMILY PHYSICIANS 2013 first_quarter PHA No Bill Number, National Physician Payment Transparency program, Continuing Medical Education reporting requirements. Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE,White House Office   649304 0 0 2013-04-19T15:52:22.343000-04:00
1383955 APOTEX CORP. bdd722be-a021-4bc0-82e8-15e0d944d1cd Q1 APOTEX CORP. 310973 APOTEX CORP. 2013 first_quarter PHA S. 504, The Fair and Immediate Release of Generics Act, relating to market blockages caused by parked 180 day exclusivity periods S. 214, The Preserve Access to Affordable Pharmaceuticals Act, relating to the legality of "reverse payment" patent settlements Federal Trade Commission v. Actavis Supreme Court Case No. 12-416, relating to federal policy on "reverse payment" settlementsFederal legislation relating to the provision of brand drug products by brand manufacturers to generic manufacturers for development testing Actelion Pharmaceutical LTD and Actelion Clinical Research Inc. V. Apotex Inc., Apotex Corp., and Roxane Laboratories Inc., United States District Court for the District of New Jersey, case 1:12-cvi-05743-NLH-AMD, relating to federal legislation regarding the provision of brand drug products by brand manufacturers to generic manufacturers for development testing Federal legisation relating to the establishment of a federal track and trace system for pharmaceuticals Federal policy relating to the adoption of an electronic labeling system for pharmaceuticals HOUSE OF REPRESENTATIVES,SENATE   200000 0 0 2013-04-19T16:00:11.443000-04:00
1384211 TAUZIN STRATEGIC NETWORKS 4dd99918-85fc-44c2-ae2d-3809d4ef6486 Q1 TAUZIN STRATEGIC NETWORKS 400786367 ENDO PHARMACEUTICALS, INC. 2013 first_quarter PHA Issues relating to incentives for tamper-resistant forumulations HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2013-04-19T16:18:33.617000-04:00
1384260 WALGREEN COMPANY 65f9ca94-3e6f-4a6f-aeae-4fc2c96955fd Q1 WALGREEN COMPANY 309071 WALGREEN COMPANY 2013 first_quarter PHA Issues related to pharmacy prescription compounding and Food and Drug Administration oversight. No legislation. HOUSE OF REPRESENTATIVES,SENATE   590000 0 0 2013-04-19T16:20:03.803000-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 1951.966ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API